HS LifeSciences ^Investor

HS LifeSciences was established in 2008 by seasoned biotech entrepreneurs with many years of experience in managing biotech companies. The lessons learned over the years have been distilled into a new business model centered on the foundation and growth of new life sciences companies without the need for conventional multiple rounds of equity-based financing. HS LifeSciences supports new life sciences companies during their foundation and early growth phases by complementing the scientific founders’ R&D vision with management, financial and commercial experience.Patient benefit remains the utmost priority for their portfolio companies and company’s veriding goal is to bring novel therapies to the market in the fastest possible manner. Their business model enables portfolio companies to pursue their role as innovation powerhouses bringing together their medical innovation with the biopharmaceutical industry.